No significant differences were found for gender, age, MTD, tumor site, surgical approach, histopathological type, differentiation, Lauren’s classification, HER2 expression, EGFR expression, and C-MET expression between the two groups (all p > 0.05) (Table 1). The gene discussed is ERBB2; the disease is neoplasm.